Literature DB >> 32982598

The role of SSDL in quality assurance in radiotherapy.

Wojciech Bulski1, Krzysztof Chełmiński1, Piotr Ulkowski1, Wioletta Ślusarczyk-Kacprzyk1, Iwona Grabska1, Paweł Kukołowicz1.   

Abstract

This paper describes the role of the Polish Secondary Standard Dosimetry Laboratory (SSDL) in quality assurance in radiotherapy by means of providing calibration of ionisation chambers, TLD postal dosimetry audits and end-to-end audits for radiation therapy. A historical review of the methods and results are presented. The influence of the SSDL in Warsaw on radiation protection of patients in Poland is discussed. The International Atomic Energy Agency together with World Health Organisation (IAEA/WHO), through its network of SSDLs around the world, propagates newly developed methods for calibration and auditing. Suitable high quality equipment was provided by the IAEA, as well as special materials and technical support to the SSDL in Warsaw. The activity of the SSDL and the services provided for Polish radiotherapy centres have resulted in a reduction of discrepancies between planned doses and doses delivered to patients. The newly tested IAEA methods of end-to-end on-site dosimetry audits allow for monitoring and improving the quality of IMRT in Poland. The traceability of standards used for the calibration of therapy level dosimeters from Polish radiotherapy centres is assured by the IAEA dosimetry laboratory. The consistency of methods performed in the Polish SSDL with the ISO:17025 norm is supervised by the Polish Centre for Accreditation - a member of International Laboratory Accreditation Cooperation (ILAC), for calibration and testing. Due to the rapid technological development of radiotherapy, special attention has to be paid to newly developed methods for dosimetry auditing and institutions which provide services for assuring radiation safety of patients.
© 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calibration; Dosimetry audits; Radiochromic films; SSDL; TLD

Year:  2020        PMID: 32982598      PMCID: PMC7498701          DOI: 10.1016/j.rpor.2020.08.003

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  5 in total

1.  Dosimetric inter-institutional comparison in European radiotherapy centres: Results of IAEA supported treatment planning system audit.

Authors:  Eduard Gershkevitsh; Csilla Pesznyak; Borislava Petrovic; Joseph Grezdo; Krzysztof Chelminski; Maria do Carmo Lopes; Joanna Izewska; Jacob Van Dyk
Journal:  Acta Oncol       Date:  2013-10-28       Impact factor: 4.089

2.  Physical and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy.

Authors:  T LoSasso; C S Chui; C C Ling
Journal:  Med Phys       Date:  1998-10       Impact factor: 4.071

3.  Testing the methodology for a dosimetric end-to-end audit of IMRT/VMAT: results of IAEA multicentre and national studies.

Authors:  Paulina Wesolowska; Dietmar Georg; Wolfgang Lechner; Pavel Kazantsev; Tomislav Bokulic; Asa Carlsson Tedgren; Emelie Adolfsson; Anna Maria Campos; Victor Gabriel Leandro Alves; Luo Suming; Wu Hao; Daniela Ekendahl; Irena Koniarova; Wojciech Bulski; Krzysztof Chelminski; José Luis Alonso Samper; Sumanth Panyam Vinatha; Sougata Rakshit; Srimanoroth Siri; Milan Tomsejm; Mikko Tenhunen; Julie Povall; Stephen F Kry; David S Followill; David I Thwaites; Joanna Izewska
Journal:  Acta Oncol       Date:  2019-08-19       Impact factor: 4.089

4.  Testing the methodology for dosimetry audit of heterogeneity corrections and small MLC-shaped fields: Results of IAEA multi-center studies.

Authors:  Joanna Izewska; Paulina Wesolowska; Godfrey Azangwe; David S Followill; David I Thwaites; Mehenna Arib; Amalia Stefanic; Claudio Viegas; Luo Suming; Daniela Ekendahl; Wojciech Bulski; Dietmar Georg
Journal:  Acta Oncol       Date:  2016-03-03       Impact factor: 4.089

5.  The Radiological Physics Center's standard dataset for small field size output factors.

Authors:  David S Followill; Stephen F Kry; Lihong Qin; Jessica Lowenstein; Andrea Molineu; Paola Alvarez; Jose Francisco Aguirre; Geoffrey S Ibbott
Journal:  J Appl Clin Med Phys       Date:  2012-08-08       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.